【レポートの概要（一部）】
Table of Contents
Table of Contents 2
List of Tables 5
List of Figures 7
Introduction 8
Peripheral Neuropathy (Sensory Neuropathy) 8
Report Guidance 8
Clinical Trials by Region 9
Clinical Trials by Country 10
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 12
Top Five Countries Contributing to Clinical Trials in Europe 13
Top Countries Contributing to Clinical Trials in North America 14
Top Countries Contributing to Clinical Trials in Middle East and Africa 15
Top Five Countries Contributing to Clinical Trials in Central and South America 16
Clinical Trials by BRIC Nations 17
Clinical Trials by G7 Nations 18
Clinical Trials in G7 Nations by Trial Status 19
Clinical Trials by E7 Nations 21
Clinical Trials in E7 Nations by Trial Status 22
Clinical Trials by Phase 23
In Progress Trials by Phase 24
Clinical Trials by Trial Status 25
Unaccomplished Trials of Peripheral Neuropathy (Sensory Neuropathy) 26
Subjects Recruited Over a Period of Time 30
Prominent Sponsors 31
Top Companies Participating in Peripheral Neuropathy (Sensory Neuropathy) Therapeutics Clinical Trials 33
Prominent Drug Comparison 35
Clinical Trial Profiles 36
Clinical Trial Overview of Top Companies 36
Pfizer Inc. 36
Clinical Trial Overview of Pfizer Inc. 36
NeurogesX, Inc. 37
Clinical Trial Overview of NeurogesX, Inc. 37
GW Pharmaceuticals plc 38
Clinical Trial Overview of GW Pharmaceuticals plc 38
Johnson & Johnson 39
Clinical Trial Overview of Johnson & Johnson 39
CSL Behring LLC 40
Clinical Trial Overview of CSL Behring LLC 40
Origin BioMed, Inc. 41
Clinical Trial Overview of Origin BioMed, Inc. 41
Endo Pharmaceuticals Inc. 42
Clinical Trial Overview of Endo Pharmaceuticals Inc. 42
Protemix Corporation Limited 43
Clinical Trial Overview of Protemix Corporation Limited 43
Neurotune AG 44
Clinical Trial Overview of Neurotune AG 44
Eisai Inc. 45
Clinical Trial Overview of Eisai Inc. 45
Lupin Limited 46
Clinical Trial Overview of Lupin Limited 46
Merck KGaA 47
Clinical Trial Overview of Merck KGaA 47
Sigma-Tau S.p.A. 48
Clinical Trial Overview of Sigma-Tau S.p.A. 48
Bristol-Myers Squibb Company 49
Clinical Trial Overview of Bristol-Myers Squibb Company 49
Octapharma AG 50
Clinical Trial Overview of Octapharma AG 50
Laboratorios Del Dr. Esteve S.A. 51
Clinical Trial Overview of Laboratorios Del Dr. Esteve S.A. 51
Cubist Pharmaceuticals, Inc. 52
Clinical Trial Overview of Cubist Pharmaceuticals, Inc. 52
Astellas Pharma Inc. 53
Clinical Trial Overview of Astellas Pharma Inc. 53
Grifols, S.A. 54
Clinical Trial Overview of Grifols, S.A. 54
Otsuka Pharmaceutical Co., Ltd. 55
Clinical Trial Overview of Otsuka Pharmaceutical Co., Ltd. 55
Clinical Trial Overview of Top Institutes / Government 56
The University of Texas M. D. Anderson Cancer Center 56
Clinical Trial Overview of The University of Texas M. D. Anderson Cancer Center 56
Odense University Hospital 57
Clinical Trial Overview of Odense University Hospital 57
National Taiwan University Hospital 58
Clinical Trial Overview of National Taiwan University Hospital 58
The National Institute of Allergy and Infectious Diseases 59
Clinical Trial Overview of The National Institute of Allergy and Infectious Diseases 59
National Center for Research Resources 60
Clinical Trial Overview of National Center for Research Resources 60
Washington University School of Medicine 61
Clinical Trial Overview of Washington University School of Medicine 61
Northwestern University 62
Clinical Trial Overview of Northwestern University 62
Erasmus MC 63
Clinical Trial Overview of Erasmus MC 63
Mayo Clinic 64
Clinical Trial Overview of Mayo Clinic 64
Johns Hopkins University 65
Clinical Trial Overview of Johns Hopkins University 65
Assistance Publique – Hopitaux de Paris 66
Clinical Trial Overview of Assistance Publique – Hopitaux de Paris 66
The University of Auckland 67
Clinical Trial Overview of The University of Auckland 67
U.S. Department of Veterans Affairs 68
Clinical Trial Overview of U.S. Department of Veterans Affairs 68
National Center for Complementary and Alternative Medicine 69
Clinical Trial Overview of National Center for Complementary and Alternative Medicine 69
Oregon Health and Science University 70
Clinical Trial Overview of Oregon Health and Science University 70
Columbia University 71
Clinical Trial Overview of Columbia University 71
Virginia Commonwealth University 72
Clinical Trial Overview of Virginia Commonwealth University 72
Skane University Hospital 73
Clinical Trial Overview of Skane University Hospital 73
National Institute of Neurological Disorders and Stroke 74
Clinical Trial Overview of National Institute of Neurological Disorders and Stroke 74
H. Lee Moffitt Cancer Center & Research Institute 75
Clinical Trial Overview of H. Lee Moffitt Cancer Center & Research Institute 75
Five Key Clinical Profiles 76
Appendix 200
Abbreviations 200
Definitions 200
Research Methodology 201
Secondary Research 201
About GlobalData 202
Contact Us 202
Disclaimer 202
Source 203
【レポート販売概要】
■ タイトル：Peripheral Neuropathy (Sensory Neuropathy)：グローバル臨床試験レビューH1, 2013■ 英文：Peripheral Neuropathy (Sensory Neuropathy) Global Clinical Trials Review, H1, 2013
■ 発行日：2013年6月30日
■ 調査会社：GlobalData
■ 商品コード：GDATA403161286
■ 調査対象地域：グローバル
- 有機EL照明パネルの世界市場2015-2019About OLED Lighting Panel OLEDs are diodes that use organic materials to produce light. These organic materials are packed between conductors that are lit up when electricity is passed through them. OLED lighting panels are used to create digital displays in electronic appliances such as TVs, computer monitors, cellphones, and gaming consoles. OLEDs are lighter and thinner than LEDs. Also, OLEDs a …
- グローバル石油・ガス産業サーベイ（2013-2014）：市場動向、マーケティング戦略Why was the report written? This report is the result of an extensive survey drawn from ICD Research’s exclusive panel of leading global oil and gas industry executives. The report provides data and analysis on global oil and gas industry suppliers’ media spend, marketing and sales strategies, and practices and business planning within the global oil and gas industry. This report includes key topi …
- Sinemet (パーキンソン病)：医薬品市場予測及び分析（～2022）Sinemet (Parkinson’s Disease) - Forecast and Market Analysis to 2022 Summary Parkinson’s disease is a progressive condition that is characterized by bradykinesia, muscular rigidity, tremor, and postural instability. As the second most common neurodegenerative disorder, Parkinson’s disease may affect individuals of any age but prevalence is increased with age and it is most common in the elderly. D …
- Consol Energy Inc.：石油・ガスの開発・生産動向及びコスト分析- Q1, 2013Consol Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis - Q1, 2013 Summary Consol Energy Inc. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for k …
- たばこ製造・販売企業分析：The Korean Tobacco and Ginseng Corporation (KTandG)Synopsis This report provides a unique and comprehensive analysis of the company Global, Regional and National Tobacco Players: The Korean Tobacco and Ginseng Corporation (KTandG), including the corporate profile, organisation structure, financial data, and competitive positioning. The analysis also details the organisation's history, merger and acquisition activity, licensing agreements, brand po …
- グローバル防衛市場の景況感レポート（2014年第3四半期）Summary “Defense Business Confidence Report Q3 2014” is a new report by Strategic Defence Intelligence that globally analyzes industry opinions on the latest economic and customer issues, and their impact on investment decisions and growth prospects within the defense industry. This report also examines executive opinion about the current and future state of the economy and its retrospective effec …
- むずむず脚症候群（RLS）治療薬の世界市場2015-2019About RLS RLS is a neurological disease; it is also known as Willis-Ekbom disease. People with RLS experience an overwhelming desire to move their legs. It leads to an unpleasant pain in the limbs, leading to a disturbance in sleep pattern of patients. The condition aggravates at night or when the person is at rest. It occurs in both genders, but higher prevalence is seen in women than men. It aff …
- 癌治療用バイオシミラーの世界市場：抗がん剤、支持療法About Oncology Biosimilars Biosimilars are follow-on versions of biological medicines that are developed after the expiry of the patent protection on the original product. Biosimilar medicines have a mechanism of action that is similar to that of the original biological medicines. Though biosimilars have many similarities to the innovator product, they are not an exact copy of the reference biopha …
- ビデオゲームの世界市場The global market for video games represents a total of nearly 62bn€ in 2014 and we estimate a strong CAGR of 8.5% for the period 2014-2018. This study follows the development of key indicators for the sector over five years and makes an appraisal of the key segments: • Home consoles • Handheld consoles • Offline computer games • Online computer games • Smartphone Game Market • Tablet Game Market …
- 出血性脳卒中の世界市場2019-2023About this market The improved diagnostic modalities for hemorrhagic stroke recovery to help market grow. For the appropriate management of hemorrhagic stroke, an adequate understanding of parenchymal hemorrhage is crucial. Since intracerebral hemorrhage is an acute clinical manifestation of the underlying cerebral small vessel diseases (cSVDs), it is essential to use improved diagnostic modalitie …
- ニューロモーフィックコンピューターの世界市場：用途別（信号処理、画像処理、データ処理、オブジェクト検出）、最終用途別、地域別、セグメント予測The global neuromorphic computing market size is expected to reach USD 6.48 billion by 2024, according to a new study by Grand View Research, Inc., registering a 20.2% CAGR during the forecast period. Rising demand for artificial intelligence and cognitive and brain robots is acting as a major growth driving factor for the market. Neuromorphic chips allow users to avail numerous advantages such as …
- カーボンナノチューブと太陽光発電の分析：Analyzing Carbon Nanotubes and PhotovoltaicsThe Sun, believed by the mankind to be just a mere centerpiece of the solar system in which we live is in reality not just a unit but an entire symphonic system which was in place much before the first humans ever walked on planet earth. This system which has been the primary energy source for origin of life on earth is in fact very well adequately positioned by nature to fulfill the needs of ener …
- Tuscany Energy Ltd.：石油・ガスの開発・生産動向及びコスト分析- Q3, 2013Tuscany Energy Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis - Q3, 2013 Summary Tuscany Energy Ltd. Oil & Gas Exploration and Production Operations and Cost Analysis is the latest report from GlobalData, the industry analysis specialists, that offers comprehensive information on the operational and financial performance of the company. The report is an essential source for …
- 虫除けの世界市場2017-2021About Mosquito Repellent The global mosquito repellent market has been witnessing positive growth over the last few years and is shaping up to be one of the top competitive markets at a global level. With the globalization of different brands and increasing media coverage, consumers are becoming more aware and are adopting these products. Thus, there are signs of opportunities being created in the …
- 合成ガス及び誘導体の世界市場Syngas is primarily used for the production of chemical derivatives, such as ammonia, methanol, hydrogen, and oxo chemicals. These derivatives are further used for the production of several other derivatives; for example, ammonia for urea and others, and methanol for formaldehyde and others. The global demand for ammonium fertilizers is anticipated to grow at a CAGR of 2.7% between 2015 and 2020. …
